POMDOCTOR Ltd (NASDAQ:POM – Get Free Report) saw a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 250,448 shares, an increase of 1,013.1% from the October 15th total of 22,500 shares. Based on an average daily trading volume, of 11,332,816 shares, the days-to-cover ratio is currently 0.0 days. Approximately 10.8% of the shares of the company are short sold.
POMDOCTOR Price Performance
POM opened at $1.58 on Wednesday. POMDOCTOR has a 12-month low of $0.43 and a 12-month high of $102.42.
POMDOCTOR (NASDAQ:POM – Get Free Report) last released its quarterly earnings data on Tuesday, September 29th. The company reported ($7.30) EPS for the quarter. The firm had revenue of $13.62 million for the quarter.
About POMDOCTOR
Our mission is to provide effective prevention and treatment solutions to alleviate patients’ sufferings from illnesses. Our vision is to become the most trustworthy medical and healthcare services platform. We are a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan. As of December 31, 2023 and 2024, the cumulative number of contracted doctors stabilized at over 212,800, while the transacting patients increased from 654,817 as of December 31, 2023 to 699,338 as of December 31, 2024.
Further Reading
- Five stocks we like better than POMDOCTOR
- Alphabet Escalates AI Chip Rivalry With NVIDIA
- Amazon’s Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?
- 3 Stocks Wall Street Likes More Than the Market Does
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
Receive News & Ratings for POMDOCTOR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for POMDOCTOR and related companies with MarketBeat.com's FREE daily email newsletter.
